Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1935

1.

Binocular coordination and reading performance during smartphone reading in intermittent exotropia.

Hirota M, Kanda H, Endo T, Morimoto T, Miyoshi T, Fujikado T.

Clin Ophthalmol. 2018 Oct 16;12:2069-2078. doi: 10.2147/OPTH.S177899. eCollection 2018.

2.

A Transcriptional Co-activator, p300 is Involved in the Epigenetic Gene Activation on Hypertrophic Response Gene Promoters in Heart Failure.

Masafumi F, Sunagawa Y, Katanasaka Y, Miyazaki Y, Wada H, Hasagawa K, Morimoto T.

Eur Cardiol. 2017 Dec;12(2):110. doi: 10.15420/ecr.2017:23:19. No abstract available.

3.

The Inhibitory Effects of Crucumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine-Induced Responses in Cardiomyocytes.

Genpei M, Sunagawa Y, Funamoto M, Shimizu K, Miyazaki Y, Katanasaka Y, Takahashi N, Kakeya H, Wada H, Hasegawa K, Morimoto T.

Eur Cardiol. 2017 Dec;12(2):107. doi: 10.15420/ecr.2017:23:16. No abstract available.

4.

Curcumin Analogue GO-Y030 Significantly Improves Pressure Overload-induced Heart Failure in Vivo.

Shimizu K, Funamoto M, Genpei M, Sunagawa Y, Katanasaka Y, Miyazaki Y, Shibata H, Wada H, Hasegawa K, Morimoto T.

Eur Cardiol. 2017 Dec;12(2):106. doi: 10.15420/ecr.2017:23:15. No abstract available.

5.

A Novel Target Molecule of Nobiletin Derived from Citrus Peels has a Therapeutic Potency Against the Development of Heart Failure.

Sunagawa Y, Funamoto M, Suzuki A, Shimizu K, Sakurai R, Katanasaka Y, Miyazaki Y, Asakawa T, Kan T, Inagaki J, Wada H, Hasegawa K, Morimoto T.

Eur Cardiol. 2017 Dec;12(2):105. doi: 10.15420/ecr.2017:23:14. No abstract available.

6.

Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker.

Komiyama M, Wada H, Yamakage H, Asahara N, Shimada S, Akao M, Morimoto T, Takahashi Y, Sawamura T, Hasegawa K.

Eur Cardiol. 2017 Dec;12(2):96. doi: 10.15420/ecr.2017:23:5. No abstract available.

7.

Acute Coronary Syndrome With Unprotected Left Main Coronary Artery Culprit - An Observation From the AOI-LMCA Registry.

Higami H, Toyofuku M, Morimoto T, Ohya M, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kadota K, Kimura T; AOI-LMCA Stenting Registry Investigators.

Circ J. 2018 Nov 9. doi: 10.1253/circj.CJ-18-0896. [Epub ahead of print]

8.

Effect of baseline renal and hepatic function on the incidence of adverse drug events: the Japan Adverse Drug Events study.

Takahashi Y, Sakuma M, Murayama H, Morimoto T.

Drug Metab Pers Ther. 2018 Nov 10. pii: /j/dmdi.ahead-of-print/dmpt-2018-0018/dmpt-2018-0018.xml. doi: 10.1515/dmpt-2018-0018. [Epub ahead of print]

PMID:
30414364
9.

GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial.

Yoshimura J, Yamakawa K, Kinoshita T, Ohta Y, Morimoto T.

Trials. 2018 Nov 8;19(1):614. doi: 10.1186/s13063-018-2971-2.

10.

Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.

Yabe M, Koike T, Ohtsubo K, Imai E, Morimoto T, Takakura H, Koh K, Yoshida K, Ogawa S, Ito E, Okuno Y, Muramatsu H, Kojima S, Matsuo K, Mori M, Hira A, Takata M, Yabe H.

Ann Hematol. 2018 Oct 27. doi: 10.1007/s00277-018-3517-0. [Epub ahead of print]

PMID:
30368588
11.

Properties of natural rubber reinforced with cellulose nanofibers based on fiber diameter distribution as estimated by differential centrifugal sedimentation.

Kumagai A, Tajima N, Iwamoto S, Morimoto T, Nagatani A, Okazaki T, Endo T.

Int J Biol Macromol. 2018 Oct 17. pii: S0141-8130(18)32686-2. doi: 10.1016/j.ijbiomac.2018.10.090. [Epub ahead of print]

PMID:
30342153
12.

A Soft, Steerable Continuum Robot That Grows via Tip Extension.

Greer JD, Morimoto TK, Okamura AM, Hawkes EW.

Soft Robot. 2018 Oct 24. doi: 10.1089/soro.2018.0034. [Epub ahead of print]

PMID:
30339050
13.

Ultrafast polarization control by terahertz fields via π-electron wavefunction changes in hydrogen-bonded molecular ferroelectrics.

Miyamoto T, Hata D, Morimoto T, Yamakawa H, Kida N, Terashige T, Iwano K, Kishida H, Horiuchi S, Okamoto H.

Sci Rep. 2018 Oct 9;8(1):15014. doi: 10.1038/s41598-018-33076-9.

14.

Influence of Baseline Platelet Count on Outcomes in Patients With Venous Thromboembolism (from the COMMAND VTE Registry).

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Watanabe H, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Am J Cardiol. 2018 Sep 14. pii: S0002-9149(18)31755-7. doi: 10.1016/j.amjcard.2018.08.053. [Epub ahead of print]

PMID:
30293653
15.

Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry.

Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators.

Heart Vessels. 2018 Oct 6. doi: 10.1007/s00380-018-1277-3. [Epub ahead of print]

PMID:
30293163
16.

The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan.

Komiyama M, Ozaki Y, Wada H, Yamakage H, Satoh-Asahara N, Morimoto T, Shimatsu A, Takahashi Y, Hasegawa K.

Trials. 2018 Oct 4;19(1):538. doi: 10.1186/s13063-018-2919-6.

17.

Sex differences in associations among metabolic syndrome, obesity, related biomarkers, and colorectal adenomatous polyp risk in a Japanese population.

Nakai K, Watari J, Tozawa K, Tamura A, Hara K, Yamasaki T, Kondo T, Kono T, Tomita T, Ohda Y, Oshima T, Fukui H, Sakurai J, Kim Y, Hayakawa Y, Fujisawa T, Morimoto T, Miwa H.

J Clin Biochem Nutr. 2018 Sep;63(2):154-163. doi: 10.3164/jcbn.18-11. Epub 2018 Apr 3.

18.

[Noble Heart Failure Therapy Using Food Compositions].

Morimoto T, Funamoto M, Sunagawa Y, Katanasaka Y, Miyazaki Y, Hasegawa K.

Yakugaku Zasshi. 2018;138(10):1263-1269. doi: 10.1248/yakushi.18-00091-2. Review. Japanese.

19.

Prepulse inhibition in Drosophila melanogaster larvae.

Matsumoto Y, Shimizu K, Arahata K, Suzuki M, Shimizu A, Takei K, Yamauchi J, Hakeda-Suzuki S, Suzuki T, Morimoto T.

Biol Open. 2018 Sep 27;7(9). pii: bio034710. doi: 10.1242/bio.034710.

20.

CLINICAL COURSE OF PARANEOPLASTIC RETINOPATHY WITH ANTI-TRPM1 AUTOANTIBODY IN JAPANESE COHORT.

Ueno S, Inooka D, Nakanishi A, Okado S, Yasuda S, Kominami T, Sayo A, Morimoto T, Kondo M, Katagiri S, Hayashi T, Terasaki H.

Retina. 2018 Sep 26. doi: 10.1097/IAE.0000000000002329. [Epub ahead of print]

PMID:
30260920
21.

Site-Selective Conversion of Azido Groups at Carbonyl α-Positions to Diazo Groups in Diazido and Triazido Compounds.

Yokoi T, Tanimoto H, Ueda T, Morimoto T, Kakiuchi K.

J Org Chem. 2018 Oct 5;83(19):12103-12121. doi: 10.1021/acs.joc.8b02074. Epub 2018 Sep 27.

PMID:
30260220
22.

Demographics, Management, and In-Hospital Outcome of Hospitalized Acute Heart Failure Syndrome Patients in Contemporary Real Clinical Practice in Japan - Observations From the Prospective, Multicenter Kyoto Congestive Heart Failure (KCHF) Registry.

Yaku H, Ozasa N, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Sasaki K, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kato T, Kimura T; KCHF Study Investigators.

Circ J. 2018 Oct 25;82(11):2811-2819. doi: 10.1253/circj.CJ-17-1386. Epub 2018 Sep 26.

23.

Probing ultrafast spin-relaxation and precession dynamics in a cuprate Mott insulator with seven-femtosecond optical pulses.

Miyamoto T, Matsui Y, Terashige T, Morimoto T, Sono N, Yada H, Ishihara S, Watanabe Y, Adachi S, Ito T, Oka K, Sawa A, Okamoto H.

Nat Commun. 2018 Sep 26;9(1):3948. doi: 10.1038/s41467-018-06312-z.

24.

Long-term effects of H. pylori eradication on epigenetic alterations related to gastric carcinogenesis.

Michigami Y, Watari J, Ito C, Nakai K, Yamasaki T, Kondo T, Kono T, Tozawa K, Tomita T, Oshima T, Fukui H, Morimoto T, Das KM, Miwa H.

Sci Rep. 2018 Sep 25;8(1):14369. doi: 10.1038/s41598-018-32717-3.

25.

Metronidazole-induced encephalopathy in a patient with pyogenic spondylitis: a case report.

Mizuta K, Sonohata M, Nozaki O, Kobatake T, Nakayama D, Morimoto T, Mawatari M.

BMC Musculoskelet Disord. 2018 Sep 18;19(1):336. doi: 10.1186/s12891-018-2255-8.

26.

Three-dimensional computed tomographic angiography with computed tomographic colonography for laparoscopic colorectal surgery.

Hiroishi A, Yamada T, Morimoto T, Horikoshi K, Nakajima Y.

Jpn J Radiol. 2018 Sep 14. doi: 10.1007/s11604-018-0775-7. [Epub ahead of print]

PMID:
30218252
27.

Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Eur Heart J Acute Cardiovasc Care. 2018 Sep 11:2048872618799993. doi: 10.1177/2048872618799993. [Epub ahead of print]

PMID:
30203659
28.

Experience of receiving care by interns reduces psychological barrier of community residents to further care in Japan.

Takamura A, Morimoto T.

Rural Remote Health. 2018 Sep;18(3):4613. doi: 10.22605/RRH4613. Epub 2018 Sep 5.

29.

Early Surgery vs. Surgery After Watchful Waiting for Asymptomatic Severe Aortic Stenosis.

Miyake M, Izumi C, Taniguchi T, Morimoto T, Amano M, Nishimura S, Kitai T, Kato T, Kadota K, Ando K, Furukawa Y, Inada T, Inoko M, Ishii K, Sakaguchi G, Yamazaki F, Koyama T, Komiya T, Yamanaka K, Nishiwaki N, Kanemitsu N, Saga T, Ogawa T, Nakayama S, Tsuneyoshi H, Iwakura A, Shiraga K, Hanyu M, Ohno N, Fukumoto A, Yamada T, Nishizawa J, Esaki J, Minatoya K, Nakagawa Y, Kimura T; CURRENT AS Registry Investigators.

Circ J. 2018 Sep 25;82(10):2663-2671. doi: 10.1253/circj.CJ-18-0416. Epub 2018 Aug 28.

30.

Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Watanabe H, Ozasa N, Morimoto T, Shiomi H, Bingyuan B, Suwa S, Nakagawa Y, Izumi C, Kadota K, Ikeguchi S, Hibi K, Furukawa Y, Kaji S, Suzuki T, Akao M, Inada T, Hayashi Y, Nanasato M, Okutsu M, Kametani R, Sone T, Sugimura Y, Kawai K, Abe M, Kaneko H, Nakamura S, Kimura T; CAPITAL-RCT investigators.

PLoS One. 2018 Aug 28;13(8):e0199347. doi: 10.1371/journal.pone.0199347. eCollection 2018.

31.

Discovery of novel spiro[chromane-2,4'-piperidine] derivatives as potent and orally bioavailable G-protein-coupled receptor 119 agonists.

Koshizawa T, Morimoto T, Watanabe G, Fukuda T, Yamasaki N, Hagita S, Sawada Y, Okuda A, Shibuya K, Ohgiya T.

Bioorg Med Chem Lett. 2018 Oct 15;28(19):3236-3241. doi: 10.1016/j.bmcl.2018.08.010. Epub 2018 Aug 15.

PMID:
30145005
32.

Mortality Effects of Prolonged Hemoperfusion Therapy Using a Polymyxin B-Immobilized Fiber Column for Patients with Septic Shock: A Sub-Analysis of the DESIRE Trial.

Kawazoe Y, Sato T, Miyagawa N, Yokokawa Y, Kushimoto S, Miyamoto K, Ohta Y, Morimoto T, Yamamura H.

Blood Purif. 2018;46(4):309-314. doi: 10.1159/000491744. Epub 2018 Aug 10.

33.

Analysis of changes on adiponectin levels and abdominal obesity after smoking cessation.

Komiyama M, Wada H, Yamakage H, Satoh-Asahara N, Sunagawa Y, Morimoto T, Ozaki Y, Shimatsu A, Takahashi Y, Hasegawa K.

PLoS One. 2018 Aug 7;13(8):e0201244. doi: 10.1371/journal.pone.0201244. eCollection 2018.

34.

Impact of concomitant tricuspid regurgitation on long-term outcomes in severe aortic stenosis.

Amano M, Izumi C, Taniguchi T, Morimoto T, Miyake M, Nishimura S, Kitai T, Kato T, Kadota K, Ando K, Furukawa Y, Inada T, Inoko M, Ishii K, Sakaguchi G, Yamazaki F, Koyama T, Komiya T, Yamanaka K, Nishiwaki N, Kanemitsu N, Saga T, Ogawa T, Nakayama S, Tsuneyoshi H, Iwakura A, Shiraga K, Hanyu M, Ohno N, Fukumoto A, Yamada T, Nishizawa J, Esaki J, Minatoya K, Nakagawa Y, Kimura T; CURRENT AS Registry Investigators.

Eur Heart J Cardiovasc Imaging. 2018 Jul 31. doi: 10.1093/ehjci/jey105. [Epub ahead of print]

PMID:
30085068
35.

Pull down assay for GTP-bound form of Sar1a reveals its activation during morphological differentiation.

Urai Y, Yamawaki M, Watanabe N, Seki Y, Morimoto T, Tago K, Homma K, Sakagami H, Miyamoto Y, Yamauchi J.

Biochem Biophys Res Commun. 2018 Sep 10;503(3):2047-2053. doi: 10.1016/j.bbrc.2018.07.157. Epub 2018 Aug 2.

PMID:
30078678
36.

Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.

Rothwell PM, Cook NR, Gaziano JM, Price JF, Belch JFF, Roncaglioni MC, Morimoto T, Mehta Z.

Lancet. 2018 Aug 4;392(10145):387-399. doi: 10.1016/S0140-6736(18)31133-4. Epub 2018 Jul 17.

37.

Social cognition and metacognition contribute to accuracy for self-evaluation of real-world functioning in patients with schizophrenia.

Nishida K, Toyomaki A, Koshikawa Y, Niimura H, Morimoto T, Tani M, Inada K, Ninomiya T, Hori H, Manabe J, Katsuki A, Kubo T, Shirahama M, Kohno K, Kinoshita T, Kusumi I, Iwanami A, Ueno T, Kishimoto T, Terao T, Nakagome K, Sumiyoshi T.

Schizophr Res. 2018 Jul 13. pii: S0920-9964(18)30415-8. doi: 10.1016/j.schres.2018.06.071. [Epub ahead of print] No abstract available.

38.

Clinical Prediction Rules to Classify Types of Stroke at Prehospital Stage.

Uchida K, Yoshimura S, Hiyama N, Oki Y, Matsumoto T, Tokuda R, Yamaura I, Saito S, Takeuchi M, Shigeta K, Araki H, Morimoto T.

Stroke. 2018 Aug;49(8):1820-1827. doi: 10.1161/STROKEAHA.118.021794.

39.

Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis.

Kanamori N, Taniguchi T, Morimoto T, Shiomi H, Ando K, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Aoyama T, Kimura T; CURRENT AS registry Investigators.

Sci Rep. 2018 Jul 4;8(1):10080. doi: 10.1038/s41598-018-28162-x.

40.

Impact of Angiographic Residual Stenosis on Clinical Outcomes After New-Generation Drug-Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials.

Watanabe H, Morimoto T, Shiomi H, Natsuaki M, Kawai K, Kozuma K, Igarashi K, Kadota K, Tanabe K, Morino Y, Hibi K, Akasaka T, Abe M, Suwa S, Muramatsu T, Kobayashi M, Dai K, Nakao K, Tarutani Y, Fujii K, Kimura T; RESET and NEXT Investigators.

J Am Heart Assoc. 2018 Jun 30;7(13). pii: e008718. doi: 10.1161/JAHA.118.008718.

41.

Z_{N} Berry Phases in Symmetry Protected Topological Phases.

Kariyado T, Morimoto T, Hatsugai Y.

Phys Rev Lett. 2018 Jun 15;120(24):247202. doi: 10.1103/PhysRevLett.120.247202.

PMID:
29956971
42.

Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials.

Kawachi H, Fujimoto D, Morimoto T, Ito M, Teraoka S, Sato Y, Nagata K, Nakagawa A, Otsuka K, Tomii K.

Clin Lung Cancer. 2018 Sep;19(5):e721-e734. doi: 10.1016/j.cllc.2018.05.014. Epub 2018 May 26.

PMID:
29934133
43.

Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.

Okada S, Morimoto T, Ogawa H, Sakuma M, Matsumoto C, Soejima H, Nakayama M, Doi N, Jinnouchi H, Waki M, Masuda I, Saito Y; JPAD Trial Investigators.

Diabetes Care. 2018 Aug;41(8):1757-1764. doi: 10.2337/dc18-0368. Epub 2018 Jun 16.

PMID:
29909377
44.

Sex differences in nicotine dependency and depressive tendency among smokers.

Komiyama M, Yamakage H, Satoh-Asahara N, Ozaki Y, Morimoto T, Shimatsu A, Takahashi Y, Hasegawa K.

Psychiatry Res. 2018 Sep;267:154-159. doi: 10.1016/j.psychres.2018.06.010. Epub 2018 Jun 9.

PMID:
29908483
45.

Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study.

Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M.

Cancer Med. 2018 Jun 14. doi: 10.1002/cam4.1600. [Epub ahead of print]

46.

Data on the effect of knockout of neruregulin-1 type III on Remak bundle structure.

Miyamoto Y, Torii T, Inoue M, Morimoto T, Yamamoto M, Yamauchi J.

Data Brief. 2018 Mar 27;18:803-807. doi: 10.1016/j.dib.2018.03.099. eCollection 2018 Jun.

47.

Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an Observation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2).

Nakatsuma K, Shiomi H, Morimoto T, Watanabe H, Nakagawa Y, Furukawa Y, Kadota K, Ando K, Ono K, Shizuta S, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Eur Heart J Qual Care Clin Outcomes. 2018 Jul 1;4(3):200-207. doi: 10.1093/ehjqcco/qcy014.

PMID:
29897437
48.

A study on indices of apixaban anticoagulation: A single-center prospective study.

Komiyama M, Miyazaki Y, Wada H, Iguchi M, Abe M, Ogawa H, Akao M, Yamakage H, Satoh-Asahara N, Sunagawa Y, Morimoto T, Hasegawa K.

J Pharmacol Sci. 2018 Jun;137(2):105-109. doi: 10.1016/j.jphs.2018.05.001. Epub 2018 May 16.

49.

Toward the Design of Personalized Continuum Surgical Robots.

Morimoto TK, Greer JD, Hawkes EW, Hsieh MH, Okamura AM.

Ann Biomed Eng. 2018 Oct;46(10):1522-1533. doi: 10.1007/s10439-018-2062-2. Epub 2018 May 31.

PMID:
29855755
50.

Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study.

Fujimoto D, Sato Y, Morimoto T, Uehara K, Ito M, Otsuka K, Nagata K, Sakanoue I, Hamakawa H, Nakagawa A, Takahashi Y, Imai Y, Tomii K.

Clin Lung Cancer. 2018 Sep;19(5):e667-e673. doi: 10.1016/j.cllc.2018.04.012. Epub 2018 May 5.

PMID:
29844002

Supplemental Content

Loading ...
Support Center